Philip J. Young
CEO and Chairman of the Board
Mr. Young, a Founder of Exactus Inc., serves as its Chairman, President, and Chief Executive Officer. He has served as a Director and Executive Officer for public and private companies for the past 20 years where has had created significant shareholder value, built integrated commercial operations, directed successful M&A transactions and was responsible for generating more the $900M through acquisitions and equity financings. Most recently as President and Chief Executive Officer and Director for AmpliPhi Biosciences from October 2011 through December 2014, a global biopharmaceutical company where he completed a transformational restructuring, collaborations, and financings. He is the former President, CEO and Director of Osteologix, Inc. from April 2007 – March 2011, having established corporate offices in Ireland after successfully completing a global divestiture of its lead program.
James R. Erickson, PhD.
Chief Business Officer
Dr. Erickson serves as our Chief Business Officer. He is a proven business development leader in the diagnostic and biopharmaceutical industries. He has held roles at companies including AGY Therapeutics, Entelos and Titan Pharmaceuticals.
In 2005, Dr. Erickson founded BayPoint Biosystems, a proteomic company focused on commercializing diagnostics and research tools technology from the M.D. Anderson Cancer Center. Under his direction, BayPoint established biomarker discovery and companion diagnostic development alliances with 12 pharmaceutical, biotechnology and life science companies. Immediately prior to joining Exactus, Inc., Dr. Erickson worked at Ferghana Partners, a boutique healthcare investment bank focusing on financings, mergers & acquisitions, and corporate partnering.
Timothy J. Ryan
Executive Vice President
Mr Ryan a Founder and Executive Vice President of Exactus Inc. Previously, he was the Founder and Managing Director, of The Shoreham Group, a Life Sciences Advisory and Investor Relations firm. In 2012, Mr. Ryan led the successful leverage buy-out of Merrill Industries, a manufacturer and distributor of packaging products. He currently serves on its board of directors. For the five years preceding Shoreham's formation in 2008, he was a Senior Vice President of the Trout Group, a Life Sciences Advisory and Investor Relations firm. Prior to that, he was the Chairman of the Board of Stracq, Inc. Mr. Ryan was a Senior Vice President of Lehman Brothers and a Principal of the Hambrecht & Quist Group.
Krassen Dimitrov, PhD.
Chief Technical Advisor
Dr. Dimitrov was appointed to serve as a member of our Board of Directors and acts as our Chief Technical Advisor. Dr. Dimitrov is the Founder and Managing Director of Digital Diagnostics, Pty. Ltd - a spinout startup company from the Australian Institute for Bioengineering and Nanotechnology (AIBN) where Dr. Dimitrov was a Group Leader from 2006 until 2012. Prior to AIBN, he was the Founder and CTO of NanoString Technologies (NASDAQ: NSTG) in Seattle (2003-2006), a company he founded to commercialize his invention of fluorescent nanobarcodes for single molecules.
Kelley A. Wendt
Chief Financial Officer
Ms. Wendt was appointed as our Chief Financial Officer and Treasurer. From December 2011 through September 2014, Ms. Wendt served as the Chief Financial Officer and consultant for Ampliphi BioSciences, a global biopharmaceutical company. Prior to joining AmpliPhi, she served as the Chief Financial Officer for Osteologix, Inc. Prior to joining Osteologix, Ms. Wendt served as the Chief Financial Officer for Crop Life America, a global chemical industry trade organization, from 2006 to 2008. She is the former Controller for Sheltering Arms Hospitals, a rehabilitation hospital company with nine facilities across the Richmond, Virginia region. Her pre-executive experience consists of several regional and national publicaccounting firms, primarily in audit and consulting roles.